Page last updated: 2024-10-20

pyrazinamide and Crohn Disease

pyrazinamide has been researched along with Crohn Disease in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, DF1
Yao, J1
Wang, LS1
Licata, A1
Barbiera, F1
Venezia, G1
Runza, G1
Craxì, A1
Almasio, PL1

Other Studies

2 other studies available for pyrazinamide and Crohn Disease

ArticleYear
Ileal amyloidosis mimicking Crohn´s disease as a cause of chronic diarrhea.
    Revista espanola de enfermedades digestivas, 2021, Volume: 113, Issue:12

    Topics: Amyloidosis; Antitubercular Agents; Crohn Disease; Diarrhea; Drug Therapy, Combination; Female; Huma

2021
A woman with a long history of abdominal pain.
    Minerva gastroenterologica e dietologica, 2004, Volume: 50, Issue:2

    Topics: Abdominal Pain; Adult; Antitubercular Agents; Cecal Diseases; Crohn Disease; Diagnosis, Differential

2004